• ქართული
  • English
  • AbbVie sees hit to Humira sales from European competition

    U.S. drugmaker AbbVie Inc on Friday lowered its overseas sales forecast for its top-selling medicine, Humira, as it agreed to larger-than-expected price cuts due to new European competition.

    Market Quotes by TradingView